Related references
Note: Only part of the references are listed.Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Mucosal healing in inflammatory bowel diseases: a systematic review
Markus F. Neurath et al.
GUT (2012)
Prognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: A prospective, multicenter study
Gianmichele Meucci et al.
INFLAMMATORY BOWEL DISEASES (2012)
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
Jean Frederic Colombel et al.
GASTROENTEROLOGY (2011)
Measurement of Disease Activity in Ulcerative Colitis: Interobserver Agreement and Predictors of Severity
Kelvin T. Thia et al.
INFLAMMATORY BOWEL DISEASES (2011)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation
Tetsuji Kudo et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Medication Nonadherence and the outcomes of patients with quiescent ulcerative colitis
S Kane et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Share Paper
